A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI

Clinical trial NCT07287852 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07287852
Sponsor: Hadassah Medical Organization
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease (AD)Mild Cognitive Impairment (MCI)

Start date: 2024-08-20
Primary completion: 2026-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.